BNP PARIBAS FINANCIAL MARKETS - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$682,029
-54.5%
29,072
-51.0%
0.00%0.0%
Q1 2024$1,497,766
-69.8%
59,294
-72.1%
0.00%
-83.3%
Q4 2023$4,955,150
+64.6%
212,212
+256.5%
0.01%
+50.0%
Q3 2023$3,010,572
+81.8%
59,521
+67.8%
0.00%
+100.0%
Q2 2023$1,656,281
-32.9%
35,474
-45.0%
0.00%
-33.3%
Q1 2023$2,468,420
+19.3%
64,517
+70.9%
0.00%0.0%
Q4 2022$2,069,248
-99.6%
37,760
+158.3%
0.00%
+200.0%
Q3 2022$497,743,000
+135.2%
14,618
-34.7%
0.00%
Q2 2022$211,661,000
+126.7%
22,398
+240.3%
0.00%
Q1 2022$93,384,000
-22.5%
6,581
+15.5%
0.00%
Q4 2021$120,470,000
+12.3%
5,696
+18.7%
0.00%
Q3 2021$107,235,000
+359.3%
4,798
+409.9%
0.00%
Q2 2021$23,346,000
-53.3%
941
-45.4%
0.00%
Q1 2021$49,955,000
+45.7%
1,722
+29.6%
0.00%
Q4 2020$34,288,000
-63.9%
1,329
-56.9%
0.00%
Q3 2020$94,864,000
+785.3%
3,081
+616.5%
0.00%
Q2 2020$10,716,000
-79.6%
430
-82.6%
0.00%
Q1 2020$52,470,000
+320.6%
2,475
+340.4%
0.00%
Q4 2019$12,474,000
-9.2%
562
-7.0%
0.00%
Q3 2019$13,741,0006040.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
University of Wisconsin Foundation 423,849$9,943,49811.19%
Propel Bio Management, LLC 327,752$7,689,0624.99%
GENERAL ATLANTIC, L.P. 5,233,989$122,789,3823.86%
SILVERARC CAPITAL MANAGEMENT, LLC 625,087$14,664,5413.46%
Yiheng Capital Management, L.P. 1,434,179$33,645,8392.71%
Redmile Group, LLC 1,614,473$37,875,5372.29%
Boxer Capital, LLC 1,676,733$39,336,1562.07%
RTW INVESTMENTS, LP 5,431,985$127,434,3681.97%
Logos Global Management LP 800,000$18,768,0001.52%
MPM BioImpact LLC 385,990$9,055,3251.41%
View complete list of AKERO THERAPEUTICS INC shareholders